As concerns about a no-deal Brexit have increased over the last couple of months and the departure date draws closer, regulators are increasing their efforts to prepare for the UK's exit from the
Saturday 29 September marked six-months until the UK leaves the European Union. There is now less than 6-months to go until the UK leaves the European Union and there remains no clarity on what will happen and that uncertainty is set to remain. Whilst a deal of some description may remain the most likely outcome, the prospect of a hard Brexit continues to rise and business has a diminishing window to make preparations and minimise the risk.
Health Select Committee reports on the impact of Brexit on medicines, medical devices and substances of human origins
On Wednesday 21 March the House of Commons Health and Social Care Committee published a report titled "Brexit: medicines, medical devices and substances of human origins". The report emphasis that it is in the best interests of both citizens and the sector for there to be "the closest possible regulatory alignment" between the UK and EU post-Brexit. It also urges the Government to publish details of its contingency plans for the sector should a hard Brexit take place, to allow companies and health organisations to put in place the necessary plans.